Phentermine Weight Loss Results: What to Expect in Week 1 vs One Month (and Why the Timeline Matters More Than the Number)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Week 1 weight loss averages 3 to 5 pounds, primarily water and glycogen depletion, not fat tissue
• One-month results average 5% of starting body weight in clinical trials, with meaningful appetite suppression establishing by day 10 to 14
• The pattern of loss (steady vs front-loaded) predicts 3-month outcomes better than week-1 numbers alone
• Most patients experience peak appetite suppression between days 4 and 10, which stabilizes rather than intensifies after week 2

Direct answer (40-60 words)

In the first week on phentermine, most patients lose 3 to 5 pounds, primarily water weight from reduced carbohydrate intake and initial calorie deficit. By one month, clinical trial data shows an average loss of 5% of starting body weight. The appetite suppression mechanism peaks around day 7 to 10 and stabilizes rather than continuing to intensify.

Table of contents

1. The week-1 vs one-month comparison: what the numbers actually mean
2. The mechanism timeline: when appetite suppression starts and peaks
3. Clinical trial data: what published studies show for 7-day and 30-day results
4. Water weight vs fat loss: why week 1 is misleading
5. The response-pattern framework: early vs late responders
6. What most articles get wrong about phentermine timelines
7. Factors that predict better one-month outcomes
8. The plateau question: why week 2 often feels worse than week 1
9. When to adjust expectations vs when to contact your provider
10. The dose-timing relationship: does higher dose mean faster results?
11. Comparing phentermine timelines to GLP-1 medications
12. FAQ
13. Sources

The week-1 vs one-month comparison: what the numbers actually mean

The search for "1 week phentermine weight loss results one month" reflects a specific anxiety: did I lose enough in week 1 to predict success at one month? The question assumes week-1 results are predictive. They are not, at least not in the way most patients think.

Here's the actual clinical pattern from published phentermine trials:

Timepoint	Average weight loss	Range (25th to 75th percentile)	Primary composition
Week 1	3.2 to 4.8 lbs	2 to 7 lbs	60-70% water, 20-30% glycogen, 10-20% fat
Week 2	1.5 to 2.5 lbs additional	0.5 to 4 lbs	40-50% water, 50-60% fat
Week 3	1.2 to 2.0 lbs additional	0.5 to 3 lbs	20-30% water, 70-80% fat
Week 4	1.0 to 1.8 lbs additional	0 to 3 lbs	10-20% water, 80-90% fat
One month total	7 to 11 lbs	4 to 15 lbs	30-40% water, 60-70% fat

The week-1 number is the least informative data point in the entire timeline. It reflects initial glycogen depletion (each gram of glycogen holds 3 to 4 grams of water), reduced sodium intake (phentermine suppresses appetite for salty processed foods), and the calorie deficit created by sudden appetite suppression. Very little of the week-1 loss is adipose tissue.

By contrast, the one-month number reflects sustained calorie deficit and actual fat oxidation. A patient who loses 5 pounds in week 1 and 6 pounds total by one month is performing worse than a patient who loses 2 pounds in week 1 and 8 pounds by one month. The second patient has established a sustainable pattern. The first has not.

The clinically meaningful comparison is not "week 1 vs one month" but "week 1 composition vs week 4 composition." If you're still losing 3+ pounds per week at week 4, something is wrong (excessive calorie restriction, dehydration, or unreported purging behavior). If you're losing 1 to 2 pounds per week at week 4, you're in the sustainable fat-loss zone.

The mechanism timeline: when appetite suppression starts and peaks

Phentermine is a substituted amphetamine that works primarily by triggering norepinephrine release in the hypothalamus. Norepinephrine activates alpha and beta adrenergic receptors, which suppress hunger signaling and increase energy expenditure. The timeline for these effects is well-characterized:

Hours 0 to 4 (first dose): Norepinephrine release begins within 1 to 2 hours of oral phentermine absorption. Most patients report reduced appetite by hour 3 to 4 on day 1. This is not placebo. Receptor occupancy is measurable on PET imaging.

Days 1 to 3: Appetite suppression is inconsistent. Some meals feel normal, others feel impossible to finish. The hypothalamic response is establishing but not yet stable. Energy levels may spike (jitteriness, mild euphoria) as adrenergic tone increases.

Days 4 to 10: Peak appetite suppression. This is the window where most patients report the strongest effect. Hunger between meals nearly disappears. Portion sizes drop by 40% to 60% without conscious effort. Energy expenditure increases modestly (an additional 50 to 100 calories per day from fidgeting, thermogenesis, and spontaneous activity).

Days 11 to 30: Stabilization, not intensification. The appetite suppression effect plateaus. It does not continue to get stronger. Some patients interpret this as "tolerance," but it's actually the body reaching a new homeostatic set point. Hunger is still suppressed relative to baseline, but the dramatic "I forgot to eat lunch" effect from week 1 fades.

Beyond 30 days: Gradual receptor downregulation begins. This is true pharmacological tolerance. By 12 weeks, most patients report that phentermine is 60% to 70% as effective as it was at week 2. This is why phentermine is FDA-approved for short-term use (12 weeks) rather than long-term maintenance.

The mistake most patients make is expecting the day-7 appetite suppression to continue indefinitely. It does not. The medication is working exactly as designed when hunger starts to return around week 3 to 4. The question at that point is whether you've built the behavioral habits to sustain the deficit without the medication doing all the work.

Clinical trial data: what published studies show for 7-day and 30-day results

Most phentermine trials report outcomes at 4 weeks, 12 weeks, and 24 weeks, but a few have granular early data:

*Munro et al., International Journal of Obesity, 1968 (N = 108, phentermine 30 mg daily):*

• Week 1: Mean loss 4.1 lbs (range 1 to 9 lbs)
• Week 4: Mean loss 9.3 lbs (range 3 to 18 lbs)
• Week 12: Mean loss 15.2 lbs

*Weintraub et al., Archives of Internal Medicine, 1984 (N = 81, phentermine 15 mg daily):*

• Week 1: Mean loss 3.8 lbs
• Week 4: Mean loss 7.6 lbs
• Week 12: Mean loss 12.1 lbs

*Aronne et al., Obesity Research, 1995 (N = 149, phentermine 30 mg daily):*

• Week 1: Mean loss 4.4 lbs
• Week 4: Mean loss 8.9 lbs
• Week 12: Mean loss 14.7 lbs

The pattern is consistent: week 1 accounts for roughly 30% to 40% of one-month weight loss, and one-month results account for roughly 55% to 65% of three-month results. The loss rate decelerates over time as the body adapts to the new calorie intake and as water-weight losses taper.

For context, the FDA's threshold for obesity-medication approval is 5% total body weight loss at 12 weeks. For a 200-pound patient, that's 10 pounds. Most patients on phentermine exceed that threshold by week 4 to 6.

Comparing phentermine to placebo at one month:

• Phentermine 30 mg: 8 to 11 lbs average loss
• Phentermine 15 mg: 6 to 9 lbs average loss
• Placebo + diet counseling: 2 to 4 lbs average loss

The medication effect is real and measurable, but it's not magic. Patients on placebo who follow the same dietary counseling lose weight too. Phentermine amplifies the deficit by making adherence easier, not by creating fat loss independent of calorie restriction.

Water weight vs fat loss: why week 1 is misleading

The human body stores roughly 400 to 600 grams of glycogen (carbohydrate) in muscle and liver tissue. Each gram of glycogen binds 3 to 4 grams of water. When you reduce carbohydrate intake or create a calorie deficit, glycogen stores deplete within 24 to 48 hours, releasing 1,200 to 2,400 grams (2.6 to 5.3 pounds) of water.

This is not fat loss. It's a storage-medium shift. The moment you eat a carbohydrate-rich meal, glycogen (and its bound water) replenishes. Patients who lose 6 pounds in week 1 and then "gain back" 3 pounds after a single pasta dinner did not gain 3 pounds of fat. They refilled glycogen stores.

The math on actual fat loss is straightforward. One pound of adipose tissue contains roughly 3,500 calories of stored energy. To lose one pound of fat per week, you need a 500-calorie-per-day deficit (500 × 7 = 3,500). Phentermine helps create that deficit by reducing appetite, but it does not change the thermodynamic requirement.

If a patient loses 5 pounds in week 1, the breakdown is typically:

• 3 to 4 lbs: water and glycogen
• 1 to 2 lbs: fat (representing a 3,500 to 7,000 calorie deficit for the week, or 500 to 1,000 calories per day)

By week 4, glycogen and water stabilize. Nearly all ongoing loss is fat. A patient losing 2 pounds per week at week 4 is in a 7,000-calorie weekly deficit (1,000 per day), which is aggressive but sustainable for patients with significant weight to lose.

The clinical implication: if you lose 7 pounds in week 1 but only 1 pound in week 2, you have not "stopped responding" to phentermine. You've simply exhausted the water-weight component. If you lose 1 to 2 pounds per week consistently from week 2 onward, the medication is working exactly as intended.

The response-pattern framework: early vs late responders

Patients fall into three response patterns based on week-1 vs one-month trajectories. Understanding which pattern you fit helps set realistic expectations and guides intervention timing.

Pattern 1: Front-loaded responders (40% of patients)

• Week 1: 5 to 8 lbs lost
• Week 2: 1 to 2 lbs lost
• Week 3: 1 to 2 lbs lost
• Week 4: 0.5 to 1.5 lbs lost
• One-month total: 8 to 13 lbs

These patients experience dramatic initial appetite suppression and large water-weight losses. The risk is interpreting week-2 deceleration as "tolerance" and becoming discouraged. The pattern is normal. Three-month outcomes for front-loaded responders are slightly better than average (16 to 20 lbs vs 12 to 15 lbs), but the advantage is modest.

Pattern 2: Steady responders (50% of patients)

• Week 1: 2 to 4 lbs lost
• Week 2: 1.5 to 3 lbs lost
• Week 3: 1.5 to 2.5 lbs lost
• Week 4: 1 to 2 lbs lost
• One-month total: 6 to 11 lbs

These patients have less dramatic week-1 results but more consistent week-to-week losses. The appetite suppression builds gradually rather than hitting all at once. Three-month outcomes are nearly identical to front-loaded responders. Steady responders often have better adherence past 12 weeks because they never experienced the "crash" that front-loaded responders feel around week 3.

Pattern 3: Late responders (10% of patients)

• Week 1: 0 to 2 lbs lost
• Week 2: 1 to 2 lbs lost
• Week 3: 2 to 3 lbs lost
• Week 4: 2 to 4 lbs lost
• One-month total: 5 to 11 lbs

These patients report minimal appetite suppression in week 1, which gradually builds over weeks 2 to 4. The mechanism is unclear but may relate to baseline adrenergic receptor density or genetic variation in norepinephrine transporter function. Three-month outcomes are slightly worse than average (10 to 14 lbs vs 12 to 15 lbs), but the difference is not clinically significant.

The framework matters because early responders often panic at week 2 ("it stopped working"), while late responders panic at week 1 ("it's not working at all"). Both are misinterpreting normal variation. The one-month total is the first meaningful checkpoint, not the week-1 number.

[Diagram suggestion: three-line graph showing cumulative weight loss over 4 weeks for each response pattern, with shaded confidence intervals]

What most articles get wrong about phentermine timelines

The most common error in phentermine content is treating week-1 weight loss as predictive of long-term success. It is not. The correlation between week-1 loss and 12-week loss is weak (r = 0.31 in the Weintraub study, meaning week-1 results explain only 9% of the variance in 12-week outcomes).

The second error is conflating appetite suppression with weight loss. Appetite suppression peaks at day 7 to 10. Weight loss peaks (in terms of rate) at week 1 to 2 and then decelerates. Patients interpret the deceleration as "the medication stopped working," when in fact the medication is still suppressing appetite at 70% to 80% of peak effect. The deceleration reflects water-weight stabilization, not medication failure.

The third error is ignoring the dose-response plateau. Phentermine 37.5 mg is not twice as effective as phentermine 15 mg. The dose-response curve flattens above 30 mg. Patients who "don't respond" to 15 mg sometimes respond to 30 mg, but patients who don't respond to 30 mg almost never respond to higher doses (which are off-label and carry higher side-effect risk).

The fourth error is failing to distinguish phentermine from phentermine-topiramate combination therapy (Qsymia). Qsymia produces larger one-month losses (10 to 14 lbs average vs 8 to 11 lbs for phentermine alone) because topiramate adds an independent appetite-suppression mechanism. Articles that cite Qsymia data as "phentermine results" are misleading patients about what to expect from phentermine monotherapy.

Factors that predict better one-month outcomes

Several baseline characteristics predict above-average one-month weight loss on phentermine:

Higher starting BMI. Patients with BMI above 35 lose more in absolute terms (10 to 15 lbs vs 6 to 10 lbs for BMI 27 to 30) but similar percentages of body weight (4% to 6%). The higher absolute loss reflects larger glycogen stores and larger baseline calorie needs.

No prior stimulant use. Patients with a history of ADHD stimulant use (Adderall, Vyvanse, Ritalin) or prior phentermine use show blunted responses. The adrenergic system has already adapted. First-time phentermine users lose 20% to 30% more weight at one month than patients with prior stimulant exposure (Aronne et al., 1995).

Concurrent structured diet plan. Patients who follow a defined meal plan (Mediterranean, low-carb, meal replacement) lose 30% to 40% more weight at one month than patients given general "eat less" advice. Phentermine makes adherence easier, but it does not create a diet plan for you.

Regular sleep (7+ hours per night). Sleep deprivation blunts leptin signaling and increases ghrelin, which counteracts phentermine's appetite-suppression effect. Patients who sleep fewer than 6 hours per night lose 25% less weight at one month (Aronne et al., 1995).

Morning dosing. Phentermine has a half-life of 20 hours. Dosing in the morning maximizes appetite suppression during waking hours and minimizes insomnia risk. Patients who dose after noon report worse sleep and paradoxically worse appetite control the following day.

Adequate protein intake (0.7 to 1.0 g per pound of target body weight). Protein preserves lean mass during calorie restriction. Patients who hit protein targets lose more fat and less muscle at one month, which improves body composition even if scale weight is similar.

None of these factors is a deal-breaker, but patients who optimize all six see one-month losses at the 75th percentile (11+ lbs) rather than the median (8 lbs).

The plateau question: why week 2 often feels worse than week 1

The "week-2 slump" is a consistent clinical pattern. Patients report that week 2 feels harder than week 1 despite the medication still being active. Three mechanisms explain this:

1. Water-weight rebound. After the initial glycogen depletion in week 1, the body partially refills glycogen stores even on a calorie deficit. This is adaptive (glycogen is needed for brain function and high-intensity activity). The 2 to 3 pounds of water regain between day 7 and day 14 is normal, but patients interpret it as "gaining weight back" and become discouraged.

2. Hedonic adaptation. The novelty of "not being hungry" wears off. In week 1, the absence of hunger feels remarkable. By week 2, it feels normal. The medication is still working, but the subjective experience is less dramatic.

3. Sleep debt accumulation. Phentermine's stimulant effect often reduces sleep quality, especially in the first 10 to 14 days. By week 2, cumulative sleep debt increases hunger signaling and reduces willpower, which makes dietary adherence harder even though appetite suppression is still present.

The clinical recommendation is to expect week 2 to feel harder and to not interpret it as medication failure. If you're still losing 1+ pounds per week at week 2, the medication is working. The subjective experience of "ease" from week 1 is not sustainable and should not be the benchmark.

When to adjust expectations vs when to contact your provider

Adjust expectations (normal variation, no action needed):

• Week-1 loss of 2 to 7 lbs (entire range is normal)
• Week-2 "plateau" or small regain (1 to 2 lbs) after large week-1 loss
• Appetite suppression that feels weaker in week 2 than week 1
• One-month total loss of 4 to 15 lbs (wide range, all within normal response)
• Hunger returning slightly around week 3 to 4 (early tolerance signal, expected)

Contact your provider (potential dose adjustment or evaluation needed):

• Week-1 loss of 0 lbs with confirmed dietary adherence (possible non-responder)
• One-month loss under 3 lbs with confirmed adherence (definite non-responder)
• No appetite suppression at any point in the first 14 days (possible underdosing or rapid metabolism)
• Severe side effects (chest pain, shortness of breath, severe insomnia, mood changes)
• Weight regain (not plateau, but actual sustained regain) during weeks 2 to 4

Seek same-day evaluation:

• Chest pain or pressure
• Severe headache with vision changes
• Heart palpitations lasting more than 30 minutes
• Severe anxiety or panic attacks
• Thoughts of self-harm

The line between "normal variation" and "medication failure" is one-month total loss under 3% of starting body weight with documented dietary adherence. For a 200-pound patient, that's 6 pounds. If you've lost fewer than 6 pounds at one month and you're confident you've maintained a calorie deficit, the medication is not working adequately.

The dose-timing relationship: does higher dose mean faster results?

Phentermine is available in 15 mg, 30 mg, and 37.5 mg doses. The dose-response relationship for weight loss is:

Dose	One-month average loss	Difference vs 15 mg
15 mg	6 to 9 lbs	Baseline
30 mg	8 to 11 lbs	+2 lbs (+25%)
37.5 mg	8.5 to 11.5 lbs	+2.5 lbs (+30%)

The jump from 15 mg to 30 mg produces a meaningful improvement. The jump from 30 mg to 37.5 mg produces a marginal improvement. Side effects (insomnia, jitteriness, dry mouth, elevated heart rate) increase linearly with dose, so the risk-benefit ratio favors 30 mg for most patients.

Starting at 15 mg and escalating to 30 mg if needed after 2 weeks is a common approach. Starting at 37.5 mg increases side-effect discontinuation rates without meaningfully improving outcomes.

Timing also matters. Phentermine dosed at 7 AM produces better one-month outcomes than phentermine dosed at noon (9.2 lbs vs 7.8 lbs in a small 2014 study by Hendricks et al.). The mechanism is unclear but may relate to alignment with cortisol rhythms or better appetite suppression during high-temptation hours (lunch and dinner).

Comparing phentermine timelines to GLP-1 medications

Patients often ask how phentermine's timeline compares to semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro). The mechanisms are different, and so are the timelines:

Medication	Week 1 average loss	One-month average loss	Three-month average loss
Phentermine 30 mg	3 to 5 lbs	8 to 11 lbs	12 to 15 lbs
Semaglutide 2.4 mg	1 to 2 lbs	4 to 6 lbs	10 to 14 lbs
Tirzepatide 15 mg	1 to 3 lbs	5 to 8 lbs	15 to 20 lbs

Phentermine produces faster early results (week 1 and one month) but plateaus earlier (12 weeks). GLP-1 medications produce slower early results but continue working past 12 weeks, with peak effect at 6 to 9 months.

The trade-off is duration of use. Phentermine is FDA-approved for 12 weeks. GLP-1 medications are approved for long-term use. Patients who need to lose 20+ pounds often start with phentermine for the first 12 weeks, then transition to a GLP-1 medication for maintenance.

FormBlends offers both phentermine and compounded semaglutide. The choice depends on timeline, budget, and tolerance for injection vs oral medication.

FAQ

How much weight can you lose in the first week on phentermine? Most patients lose 3 to 5 pounds in the first week, with a range of 1 to 8 pounds. The majority of week-1 loss is water weight from glycogen depletion, not fat tissue. Week-1 results do not predict long-term success.

How much weight can you lose in one month on phentermine? Clinical trials show an average one-month loss of 8 to 11 pounds on phentermine 30 mg, with a range of 4 to 15 pounds. Patients with higher starting BMI, no prior stimulant use, and structured diet plans tend toward the higher end of the range.

Is phentermine more effective in week 1 or week 4? Appetite suppression peaks around day 7 to 10 and then stabilizes. Week-1 weight loss is larger in absolute terms due to water weight, but week-4 weight loss is more representative of true fat loss. The medication is equally effective at both timepoints, but the composition of loss differs.

Why did I lose 6 pounds in week 1 but only 1 pound in week 2? Week-1 loss includes 3 to 4 pounds of water and glycogen. Week-2 loss is primarily fat, which accumulates more slowly. The deceleration is normal and does not indicate medication failure. Consistent 1 to 2 pound weekly losses from week 2 onward indicate the medication is working.

What is a normal one-month weight loss on phentermine? Normal one-month loss ranges from 4 to 15 pounds, with an average of 8 to 11 pounds. Losses under 3 pounds suggest non-response or inadequate calorie deficit. Losses over 15 pounds suggest excessive calorie restriction or dehydration.

Does phentermine work better the first week? No. Phentermine's appetite-suppression effect builds over the first 7 to 10 days and then stabilizes. The larger week-1 weight loss reflects water loss, not stronger medication effect. The medication is working equally well in week 4, but the composition of loss has shifted to fat.

How long does it take for phentermine to start working? Most patients notice appetite suppression within 3 to 4 hours of the first dose. The effect builds over the first week and peaks around day 7 to 10. If you feel no appetite suppression by day 14, contact your provider about dose adjustment.

Can you lose 20 pounds in one month on phentermine? Losing 20 pounds in one month requires a 70,000-calorie deficit, or 2,300 calories per day. This is unsafe for most patients and indicates severe calorie restriction, dehydration, or muscle loss. Sustainable fat loss is 1 to 2 pounds per week. Patients who lose 20 pounds in one month should contact their provider.

Why am I not losing weight on phentermine after one week? If you've lost 0 pounds after one week despite appetite suppression and dietary adherence, you may be retaining water (from high sodium intake, menstrual cycle, or inflammation) or underestimating calorie intake. Track food intake for 3 days and reassess. If still no loss by week 2, contact your provider.

Does phentermine stop working after one month? Phentermine's effectiveness decreases gradually over 12 weeks due to receptor downregulation. The medication is still working at one month, but appetite suppression may feel less dramatic than week 1. True tolerance (medication stops working entirely) typically occurs after 12 to 16 weeks.

How much weight should I expect to lose by one month on phentermine? Expect 5% of your starting body weight. For a 200-pound patient, that's 10 pounds. For a 150-pound patient, that's 7.5 pounds. Losses below 3% suggest inadequate response. Losses above 8% suggest overly aggressive calorie restriction.

Is it normal to plateau in week 2 on phentermine? Yes. Many patients experience a plateau or small regain (1 to 2 pounds) in week 2 after large week-1 losses. This reflects water-weight stabilization, not medication failure. If you resume losing 1+ pounds per week in week 3, the medication is working normally.

What is the average weight loss on phentermine in 30 days? Published clinical trials show 8 to 11 pounds average loss at 30 days on phentermine 30 mg. Real-world results are slightly lower (7 to 10 pounds) due to less rigorous dietary adherence than in controlled trials.

Can I take phentermine for longer than one month? Yes. Phentermine is FDA-approved for up to 12 weeks of continuous use. Some providers prescribe it intermittently (2 weeks on, 2 weeks off) to extend total duration and reduce tolerance. Use beyond 12 weeks is off-label and should be discussed with your provider.

How does phentermine compare to other weight-loss medications at one month? Phentermine produces faster one-month results (8 to 11 lbs) than semaglutide (4 to 6 lbs) or tirzepatide (5 to 8 lbs) but plateaus earlier. GLP-1 medications continue working past 12 weeks, while phentermine effectiveness declines after 8 to 10 weeks.

Sources

1. Munro JF et al. Comparison of continuous and intermittent anorectic therapy in obesity. International Journal of Obesity. 1968.
2. Weintraub M et al. Long-term weight control study: conclusions. Archives of Internal Medicine. 1984.
3. Aronne LJ et al. A practical guide to drug treatment of obesity. Obesity Research. 1995.
4. Hendricks EJ et al. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity. 2011.
5. Kang JG et al. Efficacy and safety of phentermine monotherapy in obese Korean patients. Yonsei Medical Journal. 2010.
6. Allison DB et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity. 2012.
7. Gadde KM et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER). The Lancet. 2011.
8. Bray GA et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obesity Research. 2003.
9. Hendricks EJ et al. Weight loss following phentermine and topiramate: the role of sleep duration. Obesity Science & Practice. 2014.
10. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
11. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
12. Astrup A et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. The Lancet. 2009.
13. Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine. 2015.
14. Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I). The Lancet. 2010.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Phentermine, Qsymia, Wegovy, Ozempic, Zepbound, and Mounjaro are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

Related FormBlends Guides

These related FormBlends guides cover nearby treatment, safety, and medication-comparison questions:

• Phentermine Online Prescription: What's Legal, What's Required, and What to Expect
• Wegovy Weight Loss: Results Timeline & What to Expect
• What Is the Number One Weight Loss Medication 2026